Close Menu

NEW YORK – Abbott Laboratories said Thursday that its first quarter Diagnostics business revenues declined slightly year over year.

For the three months ended March 31, Abbott reported overall Q1 revenues of $7.73 billion, up 3 percent from $7.53 billion in Q1 of 2019 and beating analysts' average estimate of $7.34 billion.

On an organic basis, revenues grew 4 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.